Literature DB >> 23100323

Seven functional classes of Barth syndrome mutation.

Kevin Whited1, Matthew G Baile, Pamela Currier, Steven M Claypool.   

Abstract

Patients with Barth syndrome (BTHS), a rare X-linked disease, suffer from skeletal and cardiomyopathy and bouts of cyclic neutropenia. The causative gene encodes tafazzin, a transacylase, which is the major determinant of the final acyl chain composition of the mitochondrial-specific phospholipid, CL. In addition to numerous frame shift and splice-site mutations, 36 missense mutations have been associated with BTHS. Previously, we established a BTHS-mutant panel in the yeast Saccharomyces cerevisiae that successfully models 18/21 conserved pathogenic missense mutations and defined the loss-of-function mechanism associated with a subset of the mutant tafazzins. Here, we report the biochemical and cell biological characterization of the rest of the yeast BTHS-mutant panel and in so doing identify three additional modes of tafazzin dysfunction. The largest group of mutant tafazzins is catalytically null, two mutants encode hypomorphic alleles, and another two mutants are temperature sensitive. Additionally, we have expanded the defects associated with previously characterized matrix-mislocalized-mutant tafazzins to include the rapid degradation of aggregation-prone polypeptides that correctly localize to the mitochondrial IMS. In sum, our in-depth characterization of the yeast BTHS-mutant panel has identified seven functional classes of BTHS mutation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100323      PMCID: PMC3606006          DOI: 10.1093/hmg/dds447

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  38 in total

1.  Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography.

Authors:  Devrim Acehan; Yang Xu; David L Stokes; Michael Schlame
Journal:  Lab Invest       Date:  2006-10-16       Impact factor: 5.662

2.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 3.  Protein quality control in mitochondria.

Authors:  Takashi Tatsuta
Journal:  J Biochem       Date:  2009-08-07       Impact factor: 3.387

4.  The enzymatic function of tafazzin.

Authors:  Yang Xu; Ashim Malhotra; Mindong Ren; Michael Schlame
Journal:  J Biol Chem       Date:  2006-11-02       Impact factor: 5.157

5.  Mitochondrial cardiolipin involved in outer-membrane protein biogenesis: implications for Barth syndrome.

Authors:  Natalia Gebert; Amit S Joshi; Stephan Kutik; Thomas Becker; Matthew McKenzie; Xue Li Guan; Ved P Mooga; David A Stroud; Gnanada Kulkarni; Markus R Wenk; Peter Rehling; Chris Meisinger; Michael T Ryan; Nils Wiedemann; Miriam L Greenberg; Nikolaus Pfanner
Journal:  Curr Biol       Date:  2009-12-03       Impact factor: 10.834

6.  Identification of a cardiolipin-specific phospholipase encoded by the gene CLD1 (YGR110W) in yeast.

Authors:  Andreas Beranek; Gerald Rechberger; Heide Knauer; Heimo Wolinski; Sepp D Kohlwein; Regina Leber
Journal:  J Biol Chem       Date:  2009-02-25       Impact factor: 5.157

7.  Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome.

Authors:  Riekelt H Houtkooper; Richard J Rodenburg; Charlotte Thiels; Henk van Lenthe; Femke Stet; Bwee Tien Poll-The; Janet E Stone; Colin G Steward; Ronald J Wanders; Jan Smeitink; Willem Kulik; Frédéric M Vaz
Journal:  Anal Biochem       Date:  2009-01-31       Impact factor: 3.365

8.  The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome.

Authors:  Steven M Claypool; Pinmanee Boontheung; J Michael McCaffery; Joseph A Loo; Carla M Koehler
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

9.  Distinct effects of tafazzin deletion in differentiated and undifferentiated mitochondria.

Authors:  Devrim Acehan; Zaza Khuchua; Riekelt H Houtkooper; Ashim Malhotra; Johanna Kaufman; Frédéric M Vaz; Mindong Ren; Howard A Rockman; David L Stokes; Michael Schlame
Journal:  Mitochondrion       Date:  2008-12-11       Impact factor: 4.160

10.  Cardiolipin defines the interactome of the major ADP/ATP carrier protein of the mitochondrial inner membrane.

Authors:  Steven M Claypool; Yavuz Oktay; Pinmanee Boontheung; Joseph A Loo; Carla M Koehler
Journal:  J Cell Biol       Date:  2008-09-08       Impact factor: 10.539

View more
  44 in total

Review 1.  Neutropenia in the newborn.

Authors:  Akhil Maheshwari
Journal:  Curr Opin Hematol       Date:  2014-01       Impact factor: 3.284

2.  Defining functional classes of Barth syndrome mutation in humans.

Authors:  Ya-Wen Lu; Laura Galbraith; Jenny D Herndon; Ya-Lin Lu; Mia Pras-Raves; Martin Vervaart; Antoine Van Kampen; Angela Luyf; Carla M Koehler; J Michael McCaffery; Eyal Gottlieb; Frederic M Vaz; Steven M Claypool
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

Review 3.  Mitochondrial dysfunctions in barth syndrome.

Authors:  Sagnika Ghosh; Donna M Iadarola; Writoban Basu Ball; Vishal M Gohil
Journal:  IUBMB Life       Date:  2019-02-11       Impact factor: 3.885

Review 4.  Cardiolipin signaling mechanisms: collapse of asymmetry and oxidation.

Authors:  Valerian E Kagan; Yulia Y Tyurina; Vladimir A Tyurin; Dariush Mohammadyani; Jose Pedro Friedmann Angeli; Sergei V Baranov; Judith Klein-Seetharaman; Robert M Friedlander; Rama K Mallampalli; Marcus Conrad; Hülya Bayir
Journal:  Antioxid Redox Signal       Date:  2015-03-31       Impact factor: 8.401

Review 5.  Cardiolipin in Central Nervous System Physiology and Pathology.

Authors:  Caitlin B Pointer; Andis Klegeris
Journal:  Cell Mol Neurobiol       Date:  2016-12-30       Impact factor: 5.046

Review 6.  Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.

Authors:  Nikita Ikon; Robert O Ryan
Journal:  Lipids       Date:  2017-01-09       Impact factor: 1.880

7.  Lipidomics Characterization of Biosynthetic and Remodeling Pathways of Cardiolipins in Genetically and Nutritionally Manipulated Yeast Cells.

Authors:  Yulia Y Tyurina; Wenjia Lou; Feng Qu; Vladimir A Tyurin; Dariush Mohammadyani; Jenney Liu; Maik Hüttemann; Michael A Frasso; Peter Wipf; Hülya Bayir; Miriam L Greenberg; Valerian E Kagan
Journal:  ACS Chem Biol       Date:  2016-12-16       Impact factor: 5.100

Review 8.  Metabolic biology of 3-methylglutaconic acid-uria: a new perspective.

Authors:  Betty Su; Robert O Ryan
Journal:  J Inherit Metab Dis       Date:  2014-01-10       Impact factor: 4.982

9.  Phosphatidylserine decarboxylase 1 autocatalysis and function does not require a mitochondrial-specific factor.

Authors:  Ouma Onguka; Elizabeth Calzada; Oluwaseun B Ogunbona; Steven M Claypool
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

10.  Unremodeled and remodeled cardiolipin are functionally indistinguishable in yeast.

Authors:  Matthew G Baile; Murugappan Sathappa; Ya-Wen Lu; Erin Pryce; Kevin Whited; J Michael McCaffery; Xianlin Han; Nathan N Alder; Steven M Claypool
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.